-
公开(公告)号:US09283341B2
公开(公告)日:2016-03-15
申请号:US13718084
申请日:2012-12-18
Applicant: ResMed Limited
Inventor: Anthony John Ujhazy , Jonathan Caldwell Wright , Glenn Richards , David John Bassin , Michael Berthon-Jones
CPC classification number: A61B5/4836 , A61B5/0826 , A61B5/087 , A61B5/7282 , A61B5/746 , A61M16/0051 , A61M16/0057 , A61M16/0066 , A61M16/0069 , A61M16/024 , A61M16/06 , A61M2016/0021 , A61M2016/0036 , A61M2205/3344 , A61M2230/005 , A61M2230/04 , A61M2230/10 , A61M2230/18 , A61M2230/40 , A61M2230/435 , A61M2230/63
Abstract: Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with Obstructive Sleep Disorder. Treatment may also be implemented by delivering synchronized cardiac pressure oscillations superimposed on a respiratory pressure level to provide assistance for the heart. Heart treatment pressure dose indicator may be calculated for prescribing and monitoring the delivery of treatment. The apparatus may also generate data to track heart failure condition that may be indicative of the degree of severity of heart failure based upon breathing patterns to assist in the diagnosis and management of heart failure patients.
Abstract translation: 公开了通过递送持续气道正压通气来评估患者心力衰竭状况和治疗方法和装置。 治疗由于心力衰竭患者经常发生的反射性声带闭塞引起的阻塞与治疗通常与阻塞性睡眠障碍相关的上呼吸道阻塞是不同的。 治疗也可以通过递送叠加在呼吸压力水平上的同步心脏压力振荡来提供对心脏的辅助来实现。 可以计算心脏治疗压力剂量指标,用于处方和监测治疗的递送。 该装置还可以生成跟踪心力衰竭状况的数据,该状况可以基于呼吸模式来指示心力衰竭的严重程度,以帮助心力衰竭患者的诊断和管理。
-
公开(公告)号:US20130118494A1
公开(公告)日:2013-05-16
申请号:US13718084
申请日:2012-12-18
Applicant: ResMed Limited
Inventor: Anthony John Ujhazy , Jonathan Caldwell Wright , Glenn Richards , David John Bassin , Michael Berthon-Jones
CPC classification number: A61B5/4836 , A61B5/0826 , A61B5/087 , A61B5/7282 , A61B5/746 , A61M16/0051 , A61M16/0057 , A61M16/0066 , A61M16/0069 , A61M16/024 , A61M16/06 , A61M2016/0021 , A61M2016/0036 , A61M2205/3344 , A61M2230/005 , A61M2230/04 , A61M2230/10 , A61M2230/18 , A61M2230/40 , A61M2230/435 , A61M2230/63
Abstract: Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with Obstructive Sleep Disorder. Treatment may also be implemented by delivering synchronized cardiac pressure oscillations superimposed on a respiratory pressure level to provide assistance for the heart. Heart treatment pressure dose indicator may be calculated for prescribing and monitoring the delivery of treatment. The apparatus may also generate data to track heart failure condition that may be indicative of the degree of severity of heart failure based upon breathing patterns to assist in the diagnosis and management of heart failure patients.
Abstract translation: 公开了通过递送持续气道正压通气来评估患者心力衰竭状况和治疗方法和装置。 治疗由于心力衰竭患者经常发生的反射性声带闭塞引起的阻塞与治疗通常与阻塞性睡眠障碍相关的上呼吸道阻塞是不同的。 治疗也可以通过递送叠加在呼吸压力水平上的同步心脏压力振荡来提供对心脏的辅助来实现。 可以计算心脏治疗压力剂量指标,用于处方和监测治疗的递送。 该装置还可以生成跟踪心力衰竭状况的数据,该状况可以基于呼吸模式来指示心力衰竭的严重程度,以帮助心力衰竭患者的诊断和管理。
-
公开(公告)号:US20160151014A1
公开(公告)日:2016-06-02
申请号:US15017790
申请日:2016-02-08
Applicant: ResMed Limited
Inventor: Anthony John Ujhazy , Jonathan Caldwell Wright , Glenn Richards , David John Bassin , Michael Berthon-Jones
CPC classification number: A61B5/4836 , A61B5/0826 , A61B5/087 , A61B5/7282 , A61B5/746 , A61M16/0051 , A61M16/0057 , A61M16/0066 , A61M16/0069 , A61M16/024 , A61M16/06 , A61M2016/0021 , A61M2016/0036 , A61M2205/3344 , A61M2230/005 , A61M2230/04 , A61M2230/10 , A61M2230/18 , A61M2230/40 , A61M2230/435 , A61M2230/63
Abstract: Methods and apparatus for assessing the condition of and treating patients for heart failure by the delivery of continuous positive airway pressure are disclosed. Treatment of obstruction due to reflex vocal cord closure often experienced by heart failure patients is distinguished from treatment of upper airway obstruction typically associated with Obstructive Sleep Disorder. Treatment may also be implemented by delivering synchronized cardiac pressure oscillations superimposed on a respiratory pressure level to provide assistance for the heart. Heart treatment pressure dose indicator may be calculated for prescribing and monitoring the delivery of treatment. The apparatus may also generate data to track heart failure condition that may be indicative of the degree of severity of heart failure based upon breathing patterns to assist in the diagnosis and management of heart failure patients.
-
-